Sulfonamide Intermediate Synthesis With Filtration-Based Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for synthesizing Mcl-1 inhibitors, such as compounds A1 and A2, suffer from low yield and purity, particularly in commercial production, and involve laborious purification steps like chromatography, leading to inefficiencies and impurities.

Innovation Solution

A novel synthetic process involving bromination and acetylation of (2S,3S)-butane-2,3-diol, followed by epoxidation, allylic addition, leaving group addition, nucleophilic substitution, and oxidation steps, to produce intermediates that are highly pure and can be directly processed without substantial purification, improving yield and purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If existing methods are used for synthesizing Mcl-1 inhibitors, then the synthesis process can be completed, but the yield and purity are low and laborious purification steps are required

Engineering Contradiction:
ImprovepurityVSAvoidyield
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent modifies reaction parameters including using specific reagents (NBS instead of traditional brominating agents), controlling reaction temperature (0-5°C for bromination), and selecting particular solvents (acetonitrile, dichloromethane) to optimize both purity and yield. The oxidation step uses controlled conditions with NaIO4 at 0-5°C to achieve high purity sulfonamide intermediates

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent eliminates the need for chromatography purification by designing a synthesis route that produces intermediates with sufficient purity through careful reaction control. Impurities are removed through simple filtration and washing steps, extracting only the necessary purification actions while maintaining high yield

Inventive Principle:
Principle #2Taking out (Extraction)

2Ease of manufacture

If existing methods are used for synthesizing Mcl-1 inhibitors, then the synthesis can proceed, but laborious purification steps like chromatography are required

Engineering Contradiction:
Improvepurification simplicityVSAvoidpurity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The synthesis method is designed so that the reaction conditions themselves promote the formation of pure products. The bromination and oxidation steps are controlled to minimize byproduct formation, and the intermediates crystallize or can be filtered in high purity form, making the process self-purifying to a large extent

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent removes the need for complex chromatography purification by designing a route where intermediates can be purified through simple filtration and washing. The synthesis pathway is structured to avoid difficult-to-remove impurities, extracting only the essential purification steps

Inventive Principle:
Principle #2Taking out (Extraction)

3Reliability

If existing methods are used for synthesizing Mcl-1 inhibitors, then the process can be completed, but dimeric sulfur-based impurities are formed

Engineering Contradiction:
Improveproduct consistencyVSAvoidimpurities
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent prevents dimeric sulfur-based impurity formation by controlling the oxidation conditions. The use of NaIO4 at controlled temperature (0-5°C) and the specific sequence of adding reagents prevents side reactions that would lead to dimer formation. The reaction conditions are designed in advance to counteract potential impurity formation

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The patent changes key reaction parameters including oxidation potential, temperature, and reagent addition rate to prevent the formation of dimeric impurities. The controlled oxidation conditions ensure high product consistency and reliability

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new process achieves higher yields and improved chemical and chiral purity of intermediates, avoiding dimeric sulfur-based impurities and reducing the need for laborious purification methods, enabling efficient production at both small and large scales.

Implementation Method 1

admixing compound K, NBS, and an amine base to form compound L

Methodology Applied
Scientific EffectElectrophilic addition: Chemical Bonding

Implementation Method 2

admixing compound N, a base and hydroxylamine-O-sulfonic acid to form compound Z

Methodology Applied
Scientific EffectNucleophilic substitution: Chemical Bonding

Implementation Method 3

oxidizing compound M to form compound N

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS12441681B2Synthesis of sulfonamide intermediates
Publication Date: 2025.10.14 AMGEN INC
  • US12441681B2 patent drawing
  • US12441681B2 patent drawing
  • US12441681B2 patent drawing

AI summary

Provided herein are processes for synthesizing Mcl-1 inhibitors and intermediates such as compound Z that can be used to prepare them. In particular, provided herein are processes for synthesizing compound A1, and salts or solvates thereof and compound A2, and salts and solvates thereof.